Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01609_DB08895_nanopub.RAp6RthbdrIppr4dEx6u7UTHks8R8lvQ4EQqQzxWWJcY4#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01609_DB08895 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01609_DB08895 label "DDI between Deferasirox and Tofacitinib - Tofacitinib (and other CYP3A4 substrates), when used in combination with deferasirox, may experience a decrease in concentration. It is recommended to monitor therapy. [drugbank_resource:DB01609_DB08895]" assertion.
- drugbank_resource:DB01609_DB08895 identifier "drugbank_resource:DB01609_DB08895" assertion.
- drugbank_resource:DB01609_DB08895 title "DDI between Deferasirox and Tofacitinib - Tofacitinib (and other CYP3A4 substrates), when used in combination with deferasirox, may experience a decrease in concentration. It is recommended to monitor therapy." assertion.
- drugbank:DB08895 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01609_DB08895 assertion.
- drugbank:DB01609 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01609_DB08895 assertion.